Greater Philadelphia rises two spots in top U.S. biotech clusters ranking (opens original article in a new tab)

Greater Philadelphia moved up two positions in the top U.S. biotech clusters ranking, driven by $1.3 billion in venture capital and investments from Eli Lilly and Johnson & Johnson.

• Philadelphia's biotech sector gained momentum
• Increased venture capital funding of $1.3 billion
• Major manufacturing investments from Eli Lilly and Johnson & Johnson